Amneal Pharmaceuticals, Inc.
AMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723128
In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Amneal Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 200
- +20 vs. Q3 2024
- Shares held
- 126.1M
- −16.4M (−11.5%) vs. Q3 2024
- Total value
- $998.7M
- −$186.8M (−15.8%) vs. Q3 2024
- New holders
- 42
- 85 more added
- Sold out
- 22
- 41 more reduced
3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AMRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 311 | $2.82B |
| Q1 2026 | 317 | $2.00B |
| Q4 2025 | 278 | $1.95B |
| Q3 2025 | 248 | $1.51B |
| Q2 2025 | 241 | $1.16B |
| Q1 2025 | 238 | $1.14B |
| Q4 2024 | 200 | $998.7M |
| Q3 2024 | 183 | $1.19B |
| Q2 2024 | 182 | $880.5M |
| Q1 2024 | 176 | $655.2M |
| Q4 2023 | 153 | $663.1M |
| Q3 2023 | 144 | $430.0M |
| Q2 2023 | 128 | $302.0M |
| Q1 2023 | 145 | $134.7M |
| Q4 2022 | 157 | $202.7M |
| Q3 2022 | 155 | $201.0M |
| Q2 2022 | 153 | $316.0M |
| Q1 2022 | 168 | $417.2M |
| Q4 2021 | 154 | $481.1M |
| Q3 2021 | 155 | $535.3M |
| Q2 2021 | 160 | $511.6M |
| Q1 2021 | 161 | $683.6M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Amneal Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Fosun International Ltd | 0 | $0 | 0.00% | −1,720,855−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −393,000−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −97,379−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −81,883−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −80,000−100.0% | Sold out |
| Versor Investments LP | 0 | $0 | 0.00% | −40,200−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −32,714−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −29,150−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −27,245−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −25,591−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −20,336−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −12,725−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −12,192−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,582−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −4,390−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −1,245−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Frazier Financial Advisors, LLC | 0 | $0 | 0.00% | −490−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −163−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −160−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |
| Chartwell Investment Partners, LLC | – | – | – | – | Not filed |
| ClariVest Asset Management LLC | – | – | – | – | Not filed |